JPH09157270A - Production of (6r)-tetrahydro-l-biopterin hydrochloride - Google Patents
Production of (6r)-tetrahydro-l-biopterin hydrochlorideInfo
- Publication number
- JPH09157270A JPH09157270A JP8164213A JP16421396A JPH09157270A JP H09157270 A JPH09157270 A JP H09157270A JP 8164213 A JP8164213 A JP 8164213A JP 16421396 A JP16421396 A JP 16421396A JP H09157270 A JPH09157270 A JP H09157270A
- Authority
- JP
- Japan
- Prior art keywords
- biopterin
- tetrahydro
- hydrochloride
- catalyst
- platinum black
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は次式(1)TECHNICAL FIELD The present invention relates to the following formula (1):
【0002】[0002]
【化1】 Embedded image
【0003】で表わされる(6R)−テトラヒドロ−L
−バイオプテリンの製造法、更に詳細には、テトラヒド
ロ−L−バイオプテリンの6R体を高い比率で得ること
ができる工業的な製造法に関する。(6R) -tetrahydro-L represented by
The present invention relates to a method for producing biopterin, and more particularly to an industrial method for producing a 6R-form of tetrahydro-L-biopterin at a high ratio.
【0004】[0004]
【従来の技術及び発明が解決しようとする課題】テトラ
ヒドロ−L−バイオプテリン(以下「BPH4」と略称
する)には6位の水素の立体配置により6R体と6S体
の異性体が存在する〔Furrer,H.J. ら:Helv.Chim.Act
a,62,2577(1979)〕。そして、就中(6R)−BPH4は
フェニルアラニン水酸化酵素の補酵素であると同時に、
他の芳香族アミノ酸水酸化酵素の補酵素でもある。それ
ゆえ、その欠乏は神経伝達物質であるセロトニン、ドー
パミン、ノルアドレナリン、アドレナリンなどを欠乏さ
せ、重篤な神経症状をおこさせる。また、先天性代謝異
常症の一つである悪性高フェニルアラニン血症は既存の
薬物療法では容易には治療できない難病であるが、これ
は(6R)−BPH4の欠乏によりフェニルアラニンの
チロシンへの変換が阻害されるために起ることが知られ
ている。2. Description of the Related Art Tetrahydro-L-biopterin (hereinafter abbreviated as "BPH 4 ") has 6R-isomer and 6S-isomer due to the configuration of hydrogen at the 6-position. (Furrer, HJ et al .: Helv.Chim.Act
a, 62, 2577 (1979)]. And especially (6R) -BPH 4 is a coenzyme of phenylalanine hydroxylase,
It is also a coenzyme for other aromatic amino acid hydroxylases. Therefore, the deficiency causes the deficiency of neurotransmitters such as serotonin, dopamine, noradrenaline, and adrenaline, causing severe neurological symptoms. Although malignant hyperphenylalaninemia, one of congenital metabolic disorders are intractable diseases that can not be treated as easily with existing drug therapy, which is converted to phenylalanine tyrosine by a deficiency of (6R) -BPH 4 Is known to be caused by inhibition.
【0005】悪性高フェニルアラニン血症の治療に(6
R)−BPH4の投与が考えられるが、そのためには本
品を高純度に経済的に製造する方法の開発が望まれてい
る。For the treatment of malignant hyperphenylalaninemia (6)
Although the administration of R) -BPH 4 is considered, the development of a method to economically produce this product in high purity is desired for that.
【0006】テトラヒドロ−L−バイオプテリンを製造
する方法としては、L−エリスロ−バイオプテリンを酵
素的あるいは化学的に還元する方法が知られている。就
中酵素法は6R体のみが得られるという利点はあるが、
装置及び操作が繁雑であると共に製造コストが高く工業
的方法としては不利なるを免れない。一方化学的方法に
よると、6R体と6S体の混合物を生じ、これは分割し
なければならないが、この分割は極めて困難であり、現
在その有利な分割法は知られていない。[0006] As a method for producing tetrahydro-L-biopterin, a method for enzymatically or chemically reducing L-erythro-biopterin is known. Although the enzymatic method has the advantage that only the 6R form can be obtained,
The equipment and operation are complicated, the production cost is high, and the method is inevitably disadvantageous as an industrial method. On the other hand, the chemical method produces a mixture of the 6R and 6S forms, which must be resolved, but this resolution is very difficult and no advantageous method is currently known.
【0007】従って、従来から(6R)−BPH4を高
比率で、出来得ればこれを選択的に合成する方法の開発
が望まれているが、未だ満足な方法は見出されていな
い。Therefore, it has been desired to develop a method for synthesizing (6R) -BPH 4 in a high ratio, if possible, selectively, but a satisfactory method has not yet been found.
【0008】[0008]
【課題を解決するための手段】斯かる実情において、本
発明者は鋭意研究を行った結果、L−エリスロ−バイオ
プテリン又はそのアシル誘導体を白金黒を触媒として特
定の条件下接触還元すれば、不斉合成率R/Sを著しく
高めることができ、しかもこのような高いR/S値のも
のであれば容易に(6R)−BPH4を分離収得できる
ことを見出し、本発明を完成した。Under such circumstances, the present inventor has conducted diligent research and as a result, if L-erythro-biopterin or an acyl derivative thereof is catalytically reduced under specific conditions using platinum black as a catalyst, The inventors have found that the asymmetric synthesis rate R / S can be remarkably increased, and that (6R) -BPH 4 can be easily separated and obtained with such a high R / S value, and the present invention has been completed.
【0009】従って、本発明は、L−エリスロ−バイオ
プテリン又はそのアシル誘導体(2)を白金黒を触媒と
してアミン類の存在下pH10〜13で接触還元し、アシ
ル基が存在する場合にはこれを脱離して(6R)−テト
ラヒドロ−L−バイオプテリン(1)を製造する方法で
あり、これは次の反応式によって示される。Therefore, according to the present invention, L-erythro-biopterin or its acyl derivative (2) is catalytically reduced at a pH of 10 to 13 in the presence of amines using platinum black as a catalyst. Is produced to produce (6R) -tetrahydro-L-biopterin (1), which is represented by the following reaction scheme.
【0010】[0010]
【化2】 Embedded image
【0011】(式中、RはH又はアシル基を示す)(In the formula, R represents H or an acyl group)
【0012】[0012]
【発明の実施の形態】本発明を実施するには、L−エリ
スロ−バイオプテリン又はそのアシル誘導体(2)をア
ミン類でpH10〜13に調整した水、アルコール系又は
これらの混合溶媒中で白金黒を触媒として接触還元す
る。BEST MODE FOR CARRYING OUT THE INVENTION To carry out the present invention, platinum of L-erythro-biopterin or its acyl derivative (2) is adjusted to pH 10 to 13 with amines in water, alcohol or a mixed solvent thereof. Catalytic reduction is performed using black as a catalyst.
【0013】アルコール系溶媒としては、メタノール、
エタノール、メチルセルソルブ、エチレングリコール等
が挙げられる。アミン類としては、メチルアミン、エチ
ルアミン、シクロヘキシルアミン等の第1級アミン、ジ
メチルアミン、ジエチルアミン、ピペリジン、モルホリ
ン等の第2級アミン、トリメチルアミン、トリエチルア
ミン等の第3級アミン、テトラメチルアンモニウムヒド
ロキシド、テトラエチルアンモニウムヒドロキシド、ベ
ンジルトリメチルアンモニウムヒドロキシド等の第4級
アミン等が挙げられる。このアミン類はpH10〜13に
なるように添加すればよく、pHがこれより低くなると、
不斉合成率が低下し、高くなると不斉合成率R/S及び
収率が共に低下する。As the alcohol solvent, methanol,
Ethanol, methyl cellosolve, ethylene glycol and the like can be mentioned. Examples of the amines include primary amines such as methylamine, ethylamine and cyclohexylamine; secondary amines such as dimethylamine, diethylamine, piperidine and morpholine; tertiary amines such as trimethylamine and triethylamine; tetramethylammonium hydroxide; And quaternary amines such as tetraethylammonium hydroxide and benzyltrimethylammonium hydroxide. The amines may be added so as to have a pH of 10 to 13. When the pH is lower than this,
The asymmetric synthesis rate decreases, and as the rate increases, both the asymmetric synthesis rate R / S and the yield decrease.
【0014】触媒は種々の触媒、就中白金系触媒の中で
も白金黒が特異的であり、他のものに比較し極めて高い
不斉合成率R/Sを示す。As the catalyst, platinum black is specific among various catalysts, especially platinum-based catalysts, and exhibits an extremely high asymmetric synthesis rate R / S as compared with other catalysts.
【0015】本発明方法は通常の接触還元の操作によっ
て行うことができ、反応温度は−10℃〜50℃が、H
2圧力は1kg/cm2 以上、特に1〜100kg/cm2 が好
ましい。The process of the present invention can be carried out by a usual operation of catalytic reduction, and the reaction temperature is from -10 ° C to 50 ° C.
2 pressure 1 kg / cm 2 or more, especially 1 to 100 kg / cm 2 is preferred.
【0016】このようにするとき、不斉合成率R/S約
7以上にて(6R)−BPH4又はそのアシル誘導体を
得ることができる。アシル基の一部は上記反応によって
除去されるが、まだこれが残存する場合には、塩酸等に
よって加水分解することにより容易に除去される。この
生成物を再結晶することにより高純度の(6R)−BP
H4を単離収得することができる。In this case, (6R) -BPH 4 or its acyl derivative can be obtained with an asymmetric synthesis rate R / S of about 7 or more. A part of the acyl group is removed by the above reaction, but if it still remains, it is easily removed by hydrolysis with hydrochloric acid or the like. By recrystallizing this product, high-purity (6R) -BP
H 4 can be isolated and obtained.
【0017】[0017]
【発明の効果】叙上の如く、本発明は従来化学的合成法
では製造困難であった(6R)−BPH4を高い不斉合
成率R/Sでしかも高収率にて製造することに成功した
極めて優れた発明である。INDUSTRIAL APPLICABILITY As described above, the present invention is intended to produce (6R) -BPH 4 with a high asymmetric synthesis rate R / S and a high yield, which has been difficult to produce by the conventional chemical synthesis method. It is a very successful and successful invention.
【0018】[0018]
【実施例】次に実施例を挙げて説明する。EXAMPLES Next, examples will be described.
【0019】実施例1 L−エリスロ−バイオプテリン1.0g(4.22ミリ
モル)、白金ブラック0.20gを水95mlに加え、こ
れに10%テトラエチルアンモニウムヒドロキシドを加
え、pH=12.0に調整した。これをオートクレーブに
入れ、H2圧力100kg/cm2 、温度0〜5℃、回転数
1000r.p.m.で攪拌し20時間反応させた。反応物に
濃塩酸5mlを加え、触媒を濾過して除き、減圧下浴温3
5℃以下で濃縮し、残留物を3N塩酸とエタノールの混
合溶媒より再結晶した。Example 1 1.0 g (4.22 mmol) of L-erythro-biopterin and 0.20 g of platinum black were added to 95 ml of water, and 10% tetraethylammonium hydroxide was added thereto to adjust the pH to 12.0. It was adjusted. This was placed in an autoclave, stirred at an H 2 pressure of 100 kg / cm 2 , a temperature of 0 to 5 ° C., and a rotation speed of 1000 rpm to react for 20 hours. 5 ml of concentrated hydrochloric acid was added to the reaction product, and the catalyst was removed by filtration.
After concentrating at 5 ° C. or lower, the residue was recrystallized from a mixed solvent of 3N hydrochloric acid and ethanol.
【0020】融点244.5℃(分解)の白色結晶、
(6R)−BPH42HClを1.13g得た。White crystals having a melting point of 244.5 ° C. (decomposition)
1.13 g of (6R) -BPH 4 2HCl was obtained.
【0021】 元素分析値 理論値(%) 分析値(%) C9H17Cl2N5O3 C 34.41 34.50 H 5.45 5.41 N 22.29 22.58 旋光度〔α〕D 25:−6.39°(C,0.68;0.
1N HCl)1 H−NMR(CD3OD−D2O):4.10−3.7
0(5H,m,H−C(6,7,1′,2′)),1.
40(3H,d,J=6Hz,H−C(3′))Elemental analysis value Theoretical value (%) Analysis value (%) C 9 H 17 Cl 2 N 5 O 3 C 34.41 34.50 H 5.45 5.41 N 22.29 22.58 Optical rotation [ α] D 25 : −6.39 ° (C, 0.68;
1N HCl) 1 H-NMR ( CD 3 OD-D 2 O): 4.10-3.7
0 (5H, m, H-C (6,7,1 ', 2')), 1.
40 (3H, d, J = 6Hz, HC (3 '))
【0022】実施例2 L−エリスロ−バイオプテリン1.0g(4.22ミリ
モル)、白金ブラック0.20gを水95mlに加え、こ
れに表1の塩基を加え所定pHに調整した。これをオート
クレーブに入れ、H2圧力100kg/cm2 、温度0〜5
℃、回転数1000r.p.m.で攪拌し20時間反応させ
た。反応物に濃塩酸5mlを加え、触媒を濾過して除き、
この濾液部について高速液体クロマトグラフィーで分析
し、それぞれのR/S比及び(R体+S体)の収率をも
とめた。その結果は表1の通りである。Example 2 1.0 g (4.22 mmol) of L-erythro-biopterin and 0.20 g of platinum black were added to 95 ml of water, and the base shown in Table 1 was added thereto to adjust to a predetermined pH. This was put in an autoclave, and the H 2 pressure was 100 kg / cm 2 , and the temperature was 0-5.
The mixture was stirred for 20 hours at a temperature of 1000 ° C. and a rotation speed of 1000 rpm. 5 ml of concentrated hydrochloric acid was added to the reaction product, and the catalyst was removed by filtration.
The filtrate was analyzed by high performance liquid chromatography, and the R / S ratio and the yield of (R-form + S-form) were determined. Table 1 shows the results.
【0023】高速液体クロマトグラフィー測定条件 検出器:紫外吸光光度計(測定波長:275nm) カラム:Partisil-10SCX,4.5×250 mm 移動相:30mMリン酸アンモニウム・3mM亜硫酸アンモニ
ウム(pH=3.0) 流 量:2ml/minHigh Performance Liquid Chromatography Measurement Conditions Detector: Ultraviolet absorptiometer (Measurement wavelength: 275 nm) Column: Partisil-10SCX, 4.5 × 250 mm Mobile phase: 30 mM ammonium phosphate, 3 mM ammonium sulfite (pH = 3.0) Flow rate: 2 ml / min
【0024】[0024]
【表1】 [Table 1]
【0025】実施例3 塩基として、トリエチルアミン、ジエチルアミン、エチ
ルアミン及びテトラエチルアンモニウムヒドロキシドを
使用してpHを12に調整し、反応温度とH2圧力を変え
て実施例2と同様に操作した。その結果は表2〜表5の
とおりである。Example 3 The same operation as in Example 2 was carried out by adjusting the pH to 12 using triethylamine, diethylamine, ethylamine and tetraethylammonium hydroxide as bases, and changing the reaction temperature and H 2 pressure. The results are as shown in Tables 2 to 5.
【0026】[0026]
【表2】 [Table 2]
【0027】[0027]
【表3】 [Table 3]
【0028】[0028]
【表4】 [Table 4]
【0029】[0029]
【表5】 [Table 5]
【0030】実施例4 L−エリスロ−バイオプテリン20mg、白金黒4mgを表
6の溶媒2mlに加え、表6の塩基を加えて所定pHに調整
した。これをオートクレーブに入れ、H2圧力100kg
/cm2 、表6の温度で20時間反応させた。反応物を実
施例2と同様に操作して、不斉合成率R/Sと(R体+
S体)収率を測定した。その結果は表6のとおりであ
る。Example 4 20 mg of L-erythro-biopterin and 4 mg of platinum black were added to 2 ml of the solvent shown in Table 6, and the base shown in Table 6 was added to adjust the pH to a predetermined value. Put this in an autoclave, H 2 pressure 100kg
/ Cm 2, and allowed to react for 20 hours at a temperature shown in Table 6. The reaction product was operated in the same manner as in Example 2, and the asymmetric synthesis rate R / S and (R-form +
The S form) yield was measured. Table 6 shows the results.
【0031】[0031]
【表6】 [Table 6]
【0032】実施例5 水又は有機溶媒2mlにトリアセチル−L−エリスロ−バ
イオプテリン20mg、白金黒4mg及び塩基を加え、オー
トクレーブ中で、H2気圧100kg/cm2 、温度20℃
にて20時間反応させた。反応物に3N塩酸2mlを加
え、触媒を濾去し、濾液1.5mlに濃塩酸0.5mlを加
え、3日間放置して脱アセチル化した。これを実施例2
と同条件下高速液体クロマトグラフィーで分析し、R/
Sと(R体+S体)収率を測定した。その結果は表7の
とおりである。Example 5 To 2 ml of water or an organic solvent, 20 mg of triacetyl-L-erythro-biopterin, 4 mg of platinum black and a base were added, and in an autoclave, H 2 atmospheric pressure 100 kg / cm 2 , temperature 20 ° C.
And reacted for 20 hours. 2 ml of 3N hydrochloric acid was added to the reaction product, the catalyst was filtered off, 0.5 ml of concentrated hydrochloric acid was added to 1.5 ml of the filtrate, and the mixture was left for 3 days for deacetylation. Example 2
High performance liquid chromatography under the same conditions as for R /
The yields of S and (R form + S form) were measured. The results are shown in Table 7.
【0033】[0033]
【表7】 [Table 7]
【手続補正書】[Procedure amendment]
【提出日】平成8年7月23日[Submission date] July 23, 1996
【手続補正1】[Procedure amendment 1]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】発明の名称[Correction target item name] Name of invention
【補正方法】変更[Correction method] Change
【補正内容】[Correction contents]
【発明の名称】 (6R)−テトラヒドロ−L−バイオ
プテリン塩酸塩の製造法Title of the invention (6R) -Tetrahydro-L-biopterin hydrochloride production method
【手続補正2】[Procedure amendment 2]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0007[Correction target item name] 0007
【補正方法】変更[Correction method] Change
【補正内容】[Correction contents]
【0007】従って、従来から(6R)−BPH4を高
比率で、出来得ればこれを選択的に合成し、単離収得す
る方法の開発が望まれているが、未だ満足な方法は見出
されていない。Accordingly, conventionally the (6R) -BPH 4 a high proportion, if Ere can selectively synthesize this, although the development of a method for Shutoku isolation is desired, seen yet satisfactory way Not issued.
【手続補正3】[Procedure 3]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0008[Correction target item name] 0008
【補正方法】変更[Correction method] Change
【補正内容】[Correction contents]
【0008】[0008]
【課題を解決するための手段】斯かる実情において、本
発明者は鋭意研究を行った結果、L−エリスロ−バイオ
プテリン又はそのアシル誘導体を白金黒を触媒として特
定の条件下接触還元すれば、不斉合成率R/Sを著しく
高めることができ、しかもこのような高いR/S値のも
のであれば塩酸塩として容易に高純度の(6R)−BP
H4を高収率にて分離収得できることを見出し、本発明
を完成した。Under such circumstances, the present inventor has conducted earnest research, and as a result, if L-erythro-biopterin or an acyl derivative thereof is catalytically reduced under a specific condition using platinum black as a catalyst, The asymmetric synthesis rate R / S can be remarkably increased, and if it has such a high R / S value, it can be easily used as a hydrochloride salt of high purity (6R) -BP.
The H 4 found to be able to separate Shutoku at high yield, thereby completing the present invention.
【手続補正4】[Procedure amendment 4]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0009[Correction target item name] 0009
【補正方法】変更[Correction method] Change
【補正内容】[Correction contents]
【0009】従って、本発明は、L−エリスロ−バイオ
プテリン又はそのアシル誘導体(2)を白金黒を触媒と
してアミン類の存在下pH10〜13で接触還元し、ア
シル基が存在する場合にはこれを脱離し、次いでこれを
塩酸塩として単離収得することからなる(6R)−テト
ラヒドロ−L−バイオプテリン(1)の塩酸塩を製造す
る方法であり、この接触還元反応は次の反応式によって
示される。Therefore, according to the present invention, L-erythro-biopterin or its acyl derivative (2) is catalytically reduced at a pH of 10 to 13 in the presence of amines using platinum black as a catalyst. Of (6R) -tetrahydro-L-biopterin (1), which comprises isolating and collecting the compound as a hydrochloride, and the catalytic reduction reaction is carried out according to the following reaction formula. Shown.
【手続補正5】[Procedure Amendment 5]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0016[Correction target item name] 0016
【補正方法】変更[Correction method] Change
【補正内容】[Correction contents]
【0016】このようにするとき、不斉合成率R/S約
7以上にて(6R)−BPH4又はそのアシル誘導体を
得ることができる。アシル基の一部は上記反応によって
除去されるが、まだこれが残存する場合には、塩酸等に
よって加水分解することにより容易に除去される。この
生成物を再結晶することにより高純度の(6R)−BP
H4の塩酸塩を単離収得することができる。[0016] When such may be obtained by asymmetric synthesis rate R / S to about 7 or more (6R) -BPH 4 or acyl derivatives thereof. A part of the acyl group is removed by the above reaction, but if it still remains, it is easily removed by hydrolysis with hydrochloric acid or the like. By recrystallizing this product, high-purity (6R) -BP
The hydrochloride salt of H 4 can be Shutoku isolated.
【手続補正6】[Procedure correction 6]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0017[Correction target item name] 0017
【補正方法】変更[Correction method] Change
【補正内容】[Correction contents]
【0017】[0017]
【発明の効果】叙上の如く、本発明は、従来化学的合成
法では製造困難であった(6R)−BPH4を高い不斉
合成率R/Sで合成し、しかもその6R体を塩酸塩とし
て容易に高純度、高収率にて単離収得することに成功し
た極めて優れた工業的製法である。INDUSTRIAL APPLICABILITY As described above, according to the present invention, (6R) -BPH 4 was synthesized at a high asymmetric synthesis rate R / S, which was difficult to produce by the conventional chemical synthesis method, and the 6R form was hydrochloric acid. It is an extremely excellent industrial production method that has been successfully isolated and obtained as a salt with high purity and high yield.
【手続補正7】[Procedure amendment 7]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0032[Correction target item name] 0032
【補正方法】変更[Correction method] Change
【補正内容】[Correction contents]
【0032】実施例5 水又は有機溶媒2mlにトリアセチル−L−エリスロ−
バイオプテリン20mg、白金黒4mg及び表7の塩基
を加え、所定pHに調整し、オートクレーブ中で、H2
気圧100kg/cm2、温度20℃にて20時間反応
させた。反応物に3N塩酸2mlを加え、触媒を濾去
し、濾液1.5mlに濃塩酸0.5mlを加え、3日間
放置して脱アセチル化した。これを実施例2と同条件下
高速液体クロマトグラフィーで分析し、R/Sと(R体
+S体)収率を測定した。その結果は表7のとおりであ
る。Example 5 Triacetyl-L-erythro- was added to 2 ml of water or an organic solvent.
Bio pterin 20 mg, a base platinum black 4mg and Table 7 was added, it was adjusted to a predetermined pH, in an autoclave, H 2
The reaction was carried out at a pressure of 100 kg / cm 2 and a temperature of 20 ° C. for 20 hours. 2 ml of 3N hydrochloric acid was added to the reaction product, the catalyst was removed by filtration, 0.5 ml of concentrated hydrochloric acid was added to 1.5 ml of the filtrate, and the mixture was left for 3 days to deacetylate. This was analyzed by high performance liquid chromatography under the same conditions as in Example 2 to determine the R / S and the (R-form + S-form) yield. The results are shown in Table 7.
Claims (4)
アシル誘導体を白金黒を触媒としてアミン類の存在下pH
10〜13で接触還元し、アシル基が存在する場合には
これを脱離し、次いでこれを(6R)−テトラヒドロ−
L−バイオプテリン塩酸塩として単離収得することを特
徴とする(6R)−テトラヒドロ−L−バイオプテリン
塩酸塩の製造法。1. A pH of L-erythro-biopterin or its acyl derivative in the presence of amines using platinum black as a catalyst.
Catalytic reduction with 10 to 13 is carried out to eliminate an acyl group, if present, and then (6R) -tetrahydro-
A method for producing (6R) -tetrahydro-L-biopterin hydrochloride, which is isolated and obtained as L-biopterin hydrochloride.
行うことを特徴とする請求項1記載の製造法。2. The production method according to claim 1, wherein the catalytic reduction is carried out at a H 2 pressure of 20 kg / cm 2 or more.
を特徴とする請求項1又は2記載の製造法。3. The method according to claim 1, wherein the catalytic reduction is carried out at a temperature of 20 ° C. or lower.
行うことを特徴とする請求項1〜3のいずれか1項記載
の製造法。4. The production method according to claim 1, wherein the reaction is carried out in water or / and an alcohol solvent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8164213A JP2711828B2 (en) | 1996-06-25 | 1996-06-25 | Method for producing (6R) -tetrahydro-L-biopterin hydrochloride |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8164213A JP2711828B2 (en) | 1996-06-25 | 1996-06-25 | Method for producing (6R) -tetrahydro-L-biopterin hydrochloride |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60012477A Division JPS61172876A (en) | 1985-01-28 | 1985-01-28 | Production of (6r)-tetrahydro-l-biopterin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09157270A true JPH09157270A (en) | 1997-06-17 |
JP2711828B2 JP2711828B2 (en) | 1998-02-10 |
Family
ID=15788823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8164213A Expired - Lifetime JP2711828B2 (en) | 1996-06-25 | 1996-06-25 | Method for producing (6R) -tetrahydro-L-biopterin hydrochloride |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2711828B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006112495A1 (en) * | 2005-04-14 | 2006-10-26 | Shiratori Pharmaceutical Co., Ltd. | Method for producing alpha form crystals of sapropterin hydrochloride |
EP2436379A1 (en) | 2004-11-17 | 2012-04-04 | BioMarin Pharmaceutical Inc. | Stable tablet formulation |
US8178670B2 (en) | 2008-01-07 | 2012-05-15 | Biomarin Pharmaceutical Inc. | Method of synthesizing tetrahydrobiopterin |
EP2545939A2 (en) | 2007-04-11 | 2013-01-16 | BioMarin Pharmaceutical Inc. | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
US9993481B2 (en) | 2003-11-17 | 2018-06-12 | Biomarin Pharmaceutical Inc. | Methods and compositions for the treatment of metabolic disorders |
-
1996
- 1996-06-25 JP JP8164213A patent/JP2711828B2/en not_active Expired - Lifetime
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9993481B2 (en) | 2003-11-17 | 2018-06-12 | Biomarin Pharmaceutical Inc. | Methods and compositions for the treatment of metabolic disorders |
EP2436379A1 (en) | 2004-11-17 | 2012-04-04 | BioMarin Pharmaceutical Inc. | Stable tablet formulation |
WO2006112495A1 (en) * | 2005-04-14 | 2006-10-26 | Shiratori Pharmaceutical Co., Ltd. | Method for producing alpha form crystals of sapropterin hydrochloride |
US8039617B2 (en) | 2005-04-14 | 2011-10-18 | Shiratori Pharmaceutical Co., Ltd. | Method for producing alpha form crystals of sapropterin hydrochloride |
EP2545939A2 (en) | 2007-04-11 | 2013-01-16 | BioMarin Pharmaceutical Inc. | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
EP3461503A1 (en) | 2007-04-11 | 2019-04-03 | BioMarin Pharmaceutical Inc. | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
EP4029519A1 (en) | 2007-04-11 | 2022-07-20 | BioMarin Pharmaceutical Inc. | Tetrahydrobiopterin for treating conditions associated with elevated phenylalanine levels |
US8178670B2 (en) | 2008-01-07 | 2012-05-15 | Biomarin Pharmaceutical Inc. | Method of synthesizing tetrahydrobiopterin |
Also Published As
Publication number | Publication date |
---|---|
JP2711828B2 (en) | 1998-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4713454A (en) | Preparation process of (6R)-tetrahydro-L-biopterin | |
HU228204B1 (en) | New process for the preparation of 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine and use thereof for the synthesis of tianeptine | |
JP2711828B2 (en) | Method for producing (6R) -tetrahydro-L-biopterin hydrochloride | |
JP3166125B2 (en) | Production method of indole derivatives | |
CN110092786B (en) | Method for preparing evodiamine | |
EP4349995A1 (en) | Method for using reduction to prepare (s)-nicotine | |
JPH0413357B2 (en) | ||
US6069270A (en) | Optical resolution method of (±)-3,4-dihydroxybutanoic acid | |
JPH0586393B2 (en) | ||
US5952503A (en) | Method for producing optically-active 2-piperazinecarboxylic acid derivatives | |
CA2124430A1 (en) | Process for the enantioselective synthesis of alkylated oxindoles used as intermediates in the preparation of physostigmine | |
JP2995448B2 (en) | Method for producing (6S) -tetrahydro-D-neopterin | |
EP0902011B1 (en) | Gamma-oxo-homophenylalanine derivatives and process for producing homophenylalanine derivatives by reducing the same | |
US7375245B2 (en) | N-(4-oxo-butanoic acid) -L-amino acid-ester derivatives and methods of preparation thereof | |
JPH01287064A (en) | Production of optically active aminopropanol derivative | |
EP1097135B1 (en) | Process for the preparation of an indole derivative | |
JP2674707B2 (en) | L-Biopterin manufacturing method | |
SU1240354A3 (en) | Method of producing pyrbuterol dihydrochloride | |
WO2012048451A1 (en) | Preparation process of (6r)-tetrahydrobiopterin hydrochloride | |
JP2001055397A (en) | Production of 2'-deoxyuridine | |
JPS6054361A (en) | Production of indole derivative | |
CN114621238A (en) | Method for preparing nafrafine | |
JPH06228093A (en) | Preparation of 5,6-diacetoxyindole | |
CN116640811A (en) | Preparation method of zimetapam intermediate | |
CN117736211A (en) | Synthetic method of rebaudinib intermediate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |